Skip to main content

Peer Review reports

From: Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

Original Submission
17 Dec 2007 Submitted Original manuscript
18 Jan 2008 Author responded Author comments - Charles Rosser
Resubmission - Version 2
18 Jan 2008 Submitted Manuscript version 2
29 Jan 2008 Reviewed Reviewer Report - Peter Clark
6 Feb 2008 Reviewed Reviewer Report - Ulka Vaishampayan
11 Feb 2008 Reviewed Reviewer Report - Leslie Fischer
Resubmission - Version 3
Submitted Manuscript version 3
15 Mar 2008 Author responded Author comments - Charles Rosser
Resubmission - Version 4
15 Mar 2008 Submitted Manuscript version 4
18 Mar 2008 Reviewed Reviewer Report - Peter Clark
19 Mar 2008 Reviewed Reviewer Report - Ulka Vaishampayan
1 Apr 2008 Reviewed Reviewer Report - Leslie Fischer
Resubmission - Version 5
Submitted Manuscript version 5
9 Apr 2008 Author responded Author comments - Charles Rosser
Resubmission - Version 6
9 Apr 2008 Submitted Manuscript version 6
15 Apr 2008 Author responded Author comments - Charles Rosser
Resubmission - Version 7
15 Apr 2008 Submitted Manuscript version 7
Publishing
11 May 2008 Editorially accepted
11 May 2008 Article published 10.1186/1471-2407-8-132

You can find further information about peer review here.

Back to article page
\